A study in thyroid cancer patients identified absent EZH2 expression in normal thyroid tissue and differentiated thyroid cancer, but presence in poorly differentiated (PDTC) and anaplastic thyroid cancers. This evidence concerns the gene EZH2 and thyroid gland undifferentiated (anaplastic) carcinoma.